Opening Remarks

Opening Remarks

Thursday, January 25, 2024 9:30 AM to 9:33 AM · 3 min. (Africa/Abidjan)
Conference Room 721
Conference
Sustainability

Information

We are all willing to have sustainable products for the future. The open question is: how do we get there?

This sustainability conference will start with inspiring experiences from sustainable healthcare initiatives. Presentations the focus on potential pathways and drivers for decarbonization of drug containment and delivery systems. The program gets complemented by discussion of what blocks our ecosystem from transforming and how those barriers can be overcome.

SCHOTTSCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world - because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of around 4,700 people from over 65 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house, a state-of-the-art R&D center in Switzerland, and around 130 employees in R&D, the company is focused on developing innovations for the future. SCHOTT Pharma AG & Co. KGaA, headquartered in Mainz, Germany, is part of SCHOTT AG that is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030.

Log in

See all the content and easy-to-use features by logging in or registering!